TTG Imaging Solutions

OCTOBER 27, 2021

The American Society of Nuclear Cardiology Cardiac PET Advanced Virtual Workshop – Oct 30 & 31, 2021 TTG Imaging Solutions is proud to be a Bronze Sponsor at the American Society of Nuclear Cardiology Cardiac PET Advanced Virtual Workshop. Discover how we can create a partnership that exceeds your expectations.

Nuclear Medicine 52

Nuclear Medicine Imaging Radiopharmaceuticals Diagnostic Imaging 52

TTG Imaging Solutions

JANUARY 9, 2022

The American Society of Nuclear Cardiology Cardiac PET Intensive Virtual Workshop: Jan 14 – 16, 2022 TTG Imaging Solutions is proud to sponsor the American Society of Nuclear Cardiology Cardiac PET Intensive Virtual Workshop. Request a meeting with one of our Regional Sales Managers at sales@ttgimagingsolutions.com.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Imaging Diagnostic Imaging 52

Imaging Technology

JUNE 15, 2023

The clinical trial will use this investigational radiopharmaceutical to help understand if patients have CD8+ T cells in their tumors and will, therefore, be more likely to respond to immune checkpoint inhibitors, the main class of immunotherapies currently approved for use. Lancet Oncology 2023; 24(3): e133-e143.

Radiopharmaceuticals 87

Radiopharmaceuticals Pharmaceutical Nuclear Medicine PET Scan 87

Imaging Technology

MAY 17, 2024

or with virtual access to livestreams of all scientific and educational sessions.

Radiation Oncology 52

Radiation Oncology Radiation Radiopharmaceuticals Education 52

Imaging Technology

NOVEMBER 2, 2023

To develop the AI models, GE HealthCare and VUMC retrospectively analyzed and correlated the immunotherapy treatment response of thousands of VUMC cancer patients, with their deidentified demographic, genomic, tumor, cellular, proteomic, and imaging data. Accessed on October 31, 2023. [3] 3] Shankar L.

Pharmaceutical 59

Pharmaceutical Healthcare Healthcare Clinic 59